News
Cantor Fitzgerald Initiates Coverage On Tango Therapeutics with Overweight Rating
4 Apr 24
News, Initiation, Analyst Ratings
Recap: Tango Therapeutics Q4 Earnings
18 Mar 24
Earnings
Tango Therapeutics Q4 GAAP EPS $(0.32) Misses $(0.28) Estimate, Sales $5.43M Miss $8.24M Estimate
18 Mar 24
Earnings, News
Piper Sandler Initiates Coverage On Tango Therapeutics with Overweight Rating, Announces Price Target of $18
12 Feb 24
News, Price Target, Initiation, Analyst Ratings
Press releases
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 Apr 24
Press Releases
Tango Therapeutics to Participate in Upcoming Investor Conferences
6 Mar 24
Press Releases
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024
5 Mar 24
News, Health Care, Press Releases
Pancreatic Cancer Treatments Poised for Major Advances in 2024
7 Feb 24
Small Cap, Opinion, Press Releases